--- title: "Genenta Science S.p.A. (GNTA) stock and investor profile" url: "https://aibio.space/companies/genenta-science-s-p-a/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Genenta Science S.p.A. (NASDAQ: GNTA), United States. Listing facts, related biotech companies and news on aibio.space." --- GNTA Genenta Science S.p.A. NASDAQ · United States # Genenta Science S.p.A. (GNTA) news Genenta Science S.p.A. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker GNTA, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Genenta Science S.p.A. news We have not published a story on Genenta Science S.p.A. yet. When there is news, it will appear here. ## Genenta Science S.p.A. at a glance - **Ticker**: GNTA - **Listing**: NASDAQ - **Country**: United States - **Cash, Dec 31, 2021**: $25.7 million ### Related companies - [CYPHERPUNK TECHNOLOGIES INC.](https://aibio.space/companies/cypherpunk-technologies/) NASDAQ: CYPH - [Vicarious Surgical](https://aibio.space/companies/vicarious-surgical/) OTC: RBOT - [Cronos Group](https://aibio.space/companies/cronos/) NASDAQ: CRON - [Curaleaf Holdings](https://aibio.space/companies/curaleaf/) OTC: CURLF - [Functional Brands](https://aibio.space/companies/functional-brands/) OTC: MEHA - [Ceribell](https://aibio.space/companies/ceribell/) NASDAQ: CBLL - [Quantum Cyber](https://aibio.space/companies/quantum-cyber-n-v/) NASDAQ: QUCY - [InfuSystem Holdings](https://aibio.space/companies/infusystem/) NYSE: INFU ### Also on NASDAQ - [ProKidney](https://aibio.space/companies/prokidney/) PROK - [SkinHealth Systems](https://aibio.space/companies/skinhealth-systems/) SKIN - [Lifeward](https://aibio.space/companies/lifeward/) LFWD - [Autonomix Medical](https://aibio.space/companies/autonomix-medical/) AMIX - [Lifevantage](https://aibio.space/companies/lifevantage/) LFVN - [Research Alliance Corp III](https://aibio.space/companies/research-alliance-iii/) RACC ## Genenta Science S.p.A. annual financials | Line | FY2025 | FY2024 | |---|---|---| | Research and development | [€2.7 million](https://www.sec.gov/Archives/edgar/data/1838716/000149315226014387/) | [€4.8 million](https://www.sec.gov/Archives/edgar/data/1838716/000149315226014387/) | | Net income (loss) | [-€6.5 million](https://www.sec.gov/Archives/edgar/data/1838716/000149315226014387/) | [-€8.9 million](https://www.sec.gov/Archives/edgar/data/1838716/000149315226014387/) | | Cash from operations | [-€6.9 million](https://www.sec.gov/Archives/edgar/data/1838716/000149315226014387/) | [-€6.2 million](https://www.sec.gov/Archives/edgar/data/1838716/000149315226014387/) | | Short-term investments | [€22.6 million](https://www.sec.gov/Archives/edgar/data/1838716/000149315226014387/) | [€8.1 million](https://www.sec.gov/Archives/edgar/data/1838716/000149315226014387/) | Latest balance sheet, Dec 31, 2021 (20-F): cash and equivalents $25.7 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Genenta Science S.p.A. What is the ticker symbol of Genenta Science S.p.A.? Genenta Science S.p.A. trades under the ticker GNTA on NASDAQ. Where is Genenta Science S.p.A. listed? Genenta Science S.p.A. is listed on NASDAQ. Which country or territory is Genenta Science S.p.A. listed under? Our directory records Genenta Science S.p.A. under United States. Does aibio.space cover Genenta Science S.p.A.? aibio.space lists Genenta Science S.p.A. among 2,820 public biotech companies and publishes its news here as stories appear. How much cash does Genenta Science S.p.A. have? $25.7 million in cash at Dec 31, 2021, per its 20-F. ## Investor discussion: Genenta Science S.p.A. Members talk about Genenta Science S.p.A. (GNTA). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Genenta Science S.p.A., newest first. Each line links the filing it comes from. 1. 2026-10-21 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1838716/000149315226047888/ex99-1.htm) 2. 2026-07-31 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1838716/000149315226035626/form6-k.htm) 3. 2026-07-01 Listings Reported a reverse stock split. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1838716/000149315226031546/form6-k.htm) 4. 2026-06-17 Listings Reported a reverse stock split. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1838716/000149315226029000/ex99-1.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:GNTA on TradingView](https://www.tradingview.com/symbols/NASDAQ-GNTA/). ## Listing details Genenta Science S.p.A. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker GNTA, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Genenta Science S.p.A. - **Ticker**: GNTA - **Listing**: NASDAQ - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/genenta-science-s-p-a/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Genenta Science S.p.A. (GNTA) stock and investor profile", 2026-10-31, https://aibio.space/companies/genenta-science-s-p-a/